Rockwell Medical, Inc.RMTINASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank85
5Y CAGR-36.2%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
-36.2%/yr
Long-term compound
Percentile
P85
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 15.95% |
| Q2 2025 | -4.10% |
| Q1 2025 | -6.75% |
| Q4 2024 | 7.33% |
| Q3 2024 | 19.67% |
| Q2 2024 | 9.63% |
| Q1 2024 | -5.28% |
| Q4 2023 | -4.96% |
| Q3 2023 | 51.78% |
| Q2 2023 | -24.59% |
| Q1 2023 | -44.07% |
| Q4 2022 | -20.31% |
| Q3 2022 | -33.01% |
| Q2 2022 | 506.66% |
| Q1 2022 | -289.41% |
| Q4 2021 | -77.15% |
| Q3 2021 | -39.41% |
| Q2 2021 | -30.27% |
| Q1 2021 | -41.22% |
| Q4 2020 | -18.79% |
| Q3 2020 | 150.93% |
| Q2 2020 | -27.60% |
| Q1 2020 | 2.29% |
| Q4 2019 | -15.14% |
| Q3 2019 | -26.91% |
| Q2 2019 | 43.96% |
| Q1 2019 | -27.46% |
| Q4 2018 | 97.03% |
| Q3 2018 | -24.98% |
| Q2 2018 | -38.29% |
| Q1 2018 | -18.59% |
| Q4 2017 | -17.64% |
| Q3 2017 | -7.38% |
| Q2 2017 | -13.94% |
| Q1 2017 | -4.96% |
| Q4 2016 | -4.52% |
| Q3 2016 | -6.95% |
| Q2 2016 | -5.25% |
| Q1 2016 | -7.74% |
| Q4 2015 | 1.38% |